What is TRANSDIA?
The TRANSDIA project
TRANSDIA is a collaboration to establish an islet isolation and transplant program in Mexico to help children and young adults with diabetes type 1. The partners also aim to undertake an innovative pre-clinical study that has potential to overcome current challenges and improve transplantation success. To find out more click here.
The TRANSDIA partners
TRANSDIA involves a collaboration between the Center for Molecular and Cell-based Therapeutics and the NIH Organ Donor Network in Mexico City, and Oxford Expression Technologies Ltd, Oxford Brookes University and the Oxford Islet Transplant Consortium in the UK.
The TRANSDIA project is funded through the Newton Fund – UK-Mexico Collaborative Industrial R&D Program. In the UK, funding has been provided by Innovate UK, the UK government’s innovation agency. In Mexico, funding has been provided by CONACYT.
OET Visits Key Partners in Mexico for Diabetes Type I Research
OET scientists, Dr Mine Aksular and Dr Leo Graves, recently travelled to Mexico City to spend six days visiting the Centre for Molecular and Cell-Based Therapeutics (CMCBT) as part of an international research collaboration (TRANSDIA) investigating a novel therapy for type I diabetes. Accompanied by collaborator Dr Stephen Hughes from the Nuffield Department of Surgical Sciences, Oxford University, the team were able to provide expert advice and practical guidance on key aspects of the project, helping to facilitate the transfer of technology to Mexican researchers.
Read the full article here.
Opening the Centre for molecular and Cell-Based Therapeutics (CMCBT) Lab
Members of the TRANSDIA team visited the Centre for Molecular and Cell-based Therapeutics (CMCBT) lab in Mexico City, where Professor Linda King in her role as Pro Vice-Chancellor Research & Global Partnerships at Oxford Brookes University, cut a ribbon to officially open the new suite of laboratories in Mexico City.
Members of the TRANSDIA consortium took part in an inaugural symposium to celebrate the launch of the international research collaboration in Mexico City (October 25th 2016). From the left, participants were Fernanda Murgui-Meca (CMCBT), Dr Adam Chambers (OET), Professor Robert Possee (OET), Professor Linda King (Oxford Brookes University), Professor Paul Johnson University of Oxford), Dr Stephen Hughes (University of Oxford), Mine Aksular (OET), Dr Juan Jose Plata-Munoz (CMCBT). The symposium included talks that ranged from the public health issues of Diabetes type I in Mexico, to the Oxford islet transplant programme and potential gene therapy using virus vectors, as well as an official TRANSDIA opening remarks from the UK and Mexico.